Discover Koneksa

Obtain a PDF overview of our company and offerings.

Cross Therapeutic Areas


Leptak C., et al. “What Evidence Do We Need for Biomarker Qualification?” Sci Transl Med. 2017 Nov 22;9(417):eaal4599. doi: 10.1126/scitranslmed.aal4599.


Izmailova, E.S., et al. “Wearable Devices in Clinical Trials: Hype and Hypothesis.” Clin Pharmacol Ther. 2018;104(1):42-52.


Izmailova, E.S., et al. “Evaluation of Wearable Digital Devices in a Phase I Clinical Trial.” Clin Transl Sci. 2019;12(3):247-256.


Izmailova, E.S., et al. “Continuous Monitoring Using a Wearable Device Detects Activity-Induced Heart Rate Changes After Administration of Amphetamine.” Clin Transl Sci. 2019;12(6):677-686.


Huang, Q., et al. “In-House” Data on the Outside—A Mobile Health Approach.” Clin Pharmacol Ther. 2020;107(4):948-956.


Goldsack, J.C., et al. “Verification, Analytical Validation, and Clinical Validation (V3): The Foundation of Determining Fit-for-Purpose for Biometric Monitoring Technologies (BioMeTs).” NPJ Digit Med. 2020;3(1):55.


Izmailova, E.S., et al. “Remote Digital Monitoring for Medical Product Development.” Clin Transl Sci. 2020;14(1):94-101.


Izmailova, E.S., et al. “Remote Cardiac Safety Monitoring Through the Lens of the FDA Biomarker Qualification Evidentiary Criteria Framework: A Case Study Analysis.” Digit Biomark. 2021;5(1):103-113. doi: 10.1159/000515110.